pimavanserin tartrate

FDA Drug Profile — NUPLAZID

Drug Details

Generic Name
pimavanserin tartrate
Brand Names
NUPLAZID
Application Number
NDA207318
Sponsor
Patheon Pharmaceuticals Inc.
NDC Codes
4
Dosage Forms
TABLET, COATED, CAPSULE
Routes
ORAL
Active Ingredients
PIMAVANSERIN TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE NUPLAZID ® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis [ see Clinical Studies (14) ] . NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ( 1 )